VC  Charter Life Sciences

http://www.clsvc.com





     Office Locations:

2120 East Galbraith Road
Building A, Room 161
Cincinnati, OH 45237
Phone: 513-558-6324
Fax: 513-558-6364

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Charter Life Sciences (CLS) is an early stage life sciences venture capital investor. The firm invests in medical device companies and drug development companies in roughly equal proportions with a focus on therapeutic devices, diagnostic opportunities, and both biologic and small molecule opportunities. CLS will generally make an initial portfolio investment only in Series A or Series B rounds, typically in the range of $1 to $5 million, as part of an investment syndicate of other professional venture capital investors. CLS will consider investment opportunities located anywhere in the United States, although the firm has a particular focus in the West and Midwest. Companies located outside the United States will be considered as long as they are willing to establish a U.S.-based headquarters.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    A. Barr Dolan Managing Partner
    Andrew K. Klatt Partner and CFO
    Donald C. Harrison M.D. Managing Partner
    Fred M. Schwarzer Managing Partner
    Gino Di Sciullo Ph.D. Partner

     

    Portfolio companies include:


      Amaranth Medical
        web link


      APT Pharmaceuticals
        web link


      CoMentis
        web link


      CoRepair
        web link


      EnteroMedics
        web link


      Great Lakes Pharmaceuticals
        web link


      Health Fidelity
        web link


      Inviragen
        web link


      Kereos
        web link


      KFx Medical
        web link


      Minimally Invasive Devices
        web link


      Mirabilis Medica
        web link


      Revascular Therapeutics
        web link


      Visioneering Technologies
        web link


      Xlumena
        web link


     

    Recent News: